Martinez M T, Ramos O, Carretero N, Calvillan M, Gutierrez-Lopez M D, Cuesta P, Serrano-Rios M
Hospital Clinico San Carlos, Universidad Complutense de Madrid, Department of Internal Medicine II, Spain.
Diabete Metab. 1994 Nov-Dec;20(6):522-5.
To study serum Lp(a) levels and other metabolic cardiovascular risk factors in children with Type 1 diabetes mellitus (DM) compared to sex and age matched nondiabetic children. The correlation of Lp(a) serum levels and other lipid parameters with HbA1c concentrations in diabetic children was investigated.
Transversal observational study.
36 C-peptide negative Type 1 DM children without microalbuminuria and no macromicrovascular or neurological complications, aged 8 to 15 years; 17 boys, 19 girls. Mean duration of Type 1 DM was 4.99 +/- 3.04 years, daily insulin need were 32.79 +/- 12.64 Units. 41 healthy children with no family history of DM, aged from 8 to 15 years, 26 boys, 15 girls, were studied in parallel as the control group.
Serum total cholesterol (TC) and triglycerides (TG) were assayed by enzymatic methods, high-density lipoprotein (HDL) cholesterol by enzymatic method after precipitation of very-low-density (VLDL) and low-density lipoprotein (LDL) fractions. The LDL fractions was estimated after serum precipitation as the difference between total cholesterol and supernatant cholesterol concentrations. Apo-AI, apo-AII and apo-B were measured by radial immunodiffusion assays. Serum Lp(a) was measured by monoclonal anti-Lp(a) antibody (ELISA) method and whole blood glycosylated hemoglobin A1c (HbA1c) by high resolution liquid chromatography.
HbA1c concentration in diabetic children was 7.51 +/- 54% vs 4.16 +/- 0.35% in non diabetic children. Lp(a) serum levels did not significantly differ among both groups (25 +/- 22 mg/dl in diabetics subjects, 22 +/- 22 mg/dl in controls). Significant correlation was found between HbA1c levels and each of TC, LDL and TG serum concentrations in the diabetic group. Lp(a) levels were correlated with glycated hemoglobin in the whole diabetic group. But, in the 2 patients with the poorest metabolic control (HbA1c 10.5%) were excluded, the correlation disappeared.
In 36 children aged 5-15 years with uncomplicated Type 1 DM lasting less than 15 years, Lp(a) serum levels did not differ from age-matched controls but highest Lp(a) values were associated with poorest metabolic control.
研究1型糖尿病(DM)患儿与性别和年龄匹配的非糖尿病儿童相比的血清脂蛋白(a)[Lp(a)]水平及其他代谢性心血管危险因素。研究糖尿病患儿中Lp(a)血清水平及其他血脂参数与糖化血红蛋白A1c(HbA1c)浓度的相关性。
横向观察性研究。
36例C肽阴性的1型糖尿病患儿,无微量白蛋白尿,无大微血管或神经并发症,年龄8至15岁;17例男孩,19例女孩。1型糖尿病平均病程为4.99±3.04年,每日胰岛素需求量为32.79±12.64单位。41例无糖尿病家族史的健康儿童,年龄8至15岁,26例男孩,15例女孩,作为对照组并行研究。
采用酶法测定血清总胆固醇(TC)和甘油三酯(TG),采用酶法在极低密度脂蛋白(VLDL)和低密度脂蛋白(LDL)组分沉淀后测定高密度脂蛋白(HDL)胆固醇。血清沉淀后,LDL组分按总胆固醇与上清液胆固醇浓度之差估算。采用放射免疫扩散法测定载脂蛋白A-I(Apo-AI)、载脂蛋白A-II(apo-AII)和载脂蛋白B(apo-B)。采用单克隆抗Lp(a)抗体(ELISA)法测定血清Lp(a),采用高分辨率液相色谱法测定全血糖化血红蛋白A1c(HbA1c)。
糖尿病患儿的HbA1c浓度为7.51±54%,而非糖尿病儿童为4.16±0.35%。两组间Lp(a)血清水平无显著差异(糖尿病患者为25±22mg/dl,对照组为22±22mg/dl)。糖尿病组中,HbA1c水平与TC、LDL和TG血清浓度均显著相关。整个糖尿病组中,Lp(a)水平与糖化血红蛋白相关。但是,排除2例代谢控制最差(HbA1c为10.5%)的患者后,相关性消失。
在36例年龄5至15岁、病程少于15年且无并发症的1型糖尿病患儿中,Lp(a)血清水平与年龄匹配的对照组无差异,但Lp(a)值最高者与代谢控制最差相关。